Drug Information

General Information
Drug ID
DR00326
Drug Name
Sarcosine
Synonyms
(Methylamino)acetic acid; (Methylamino)ethanoic acid; 2-(methylamino)acetic acid; AI3-15410; Acetic acid, (methylamino)-; BRN 1699442; CHEBI:15611; CHEMBL304383; Cocoylsarcosine; EINECS 203-538-6; FSYKKLYZXJSNPZ-UHFFFAOYSA-N; Glycine, N-methyl-; H-Sar-OH; Methylamino-Acetic Acid; Methylaminoacetic acid; Methylglycine; N-Methyl glycine; N-Methylaminoacetic acid; N-methyl-Glycine; N-methylglycine; Polysarcosine; SAR; Sarcosin; Sarcosine, 98%; Sarcosinic acid; Sargosine hydrochloride; UNII-Z711V88R5F; Z711V88R5F
Drug Type
Small molecular drug
Indication Schizophrenia [ICD11: 6A20] Phase 2 [1]
Structure
3D MOL 2D MOL
Formula
C3H7NO2
Canonical SMILES
CNCC(=O)O
InChI
InChI=1S/C3H7NO2/c1-4-2-3(5)6/h4H,2H2,1H3,(H,5,6)
InChIKey
FSYKKLYZXJSNPZ-UHFFFAOYSA-N
CAS Number
CAS 107-97-1
Pharmaceutical Properties Molecular Weight 89.09 Topological Polar Surface Area 49.3
Heavy Atom Count 6 Rotatable Bond Count 2
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 3
XLogP
-2.8
PubChem CID
1088
PubChem SID
102851555 , 103260070 , 103928493 , 104296726 , 104668562 , 10503566 , 117480502 , 123055190 , 124799851 , 125270146 , 125324385 , 125337494 , 126523128 , 126595739 , 126604360 , 126646789 , 126676630 , 127319579 , 127319580 , 14842807 , 24439439 , 24848035 , 24899761 , 3135884 , 3513 , 38327572 , 413393 , 50045496 , 50370559 , 5077689 , 51075215 , 57260822 , 57264366 , 57304408 , 57320726 , 589772 , 608062 , 7888914 , 7890376 , 7979965 , 8143301 , 8150965 , 85089252 , 85164986 , 85244545 , 87243947 , 87350276 , 87572403 , 88828665 , 92297466
ChEBI ID
CHEBI:15611
TTD Drug ID
D0YF9S
DT(s) Transporting This Drug GLYT1 Transporter Info Sodium- and chloride-dependent glycine transporter 1 Substrate [2]
References
1 ClinicalTrials.gov (NCT01503359) Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in Schizophrenia
2 Glycine is taken up through GLYT1 and GLYT2 transporters into mouse spinal cord axon terminals and causes vesicular and carrier-mediated release of its proposed co-transmitter GABA. J Neurochem. 2001 Mar;76(6):1823-32.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.